Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Crame.

Yesterday, March 10, 2015, 98 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1,617.00 to $5,999,989.08.

Highlighted Stocks Traded by Insiders:

Primerica (PRI) - FREE Research Report

Britt Chess E., who is Executive Vice President at Primerica, sold 5,097 shares at $51.87 on March 10, 2015. Following this transaction, the Executive Vice President owned 65,499 shares meaning that the stake was reduced by 7.22% with the 5,097-share transaction.

The shares most recently traded at $51.08, down $0.79, or 1.55% since the insider transaction. Historical insider transactions for Primerica go as follows:

  • 4-Week # shares sold: 22,177
  • 12-Week # shares sold: 27,177
  • 24-Week # shares sold: 90,177

The average volume for Primerica has been 227,900 shares per day over the past 30 days. Primerica has a market cap of $2.7 billion and is part of the financial sector and insurance industry. Shares are down 6.41% year-to-date as of the close of trading on Tuesday.

Primerica, Inc., together with its subsidiaries, distributes financial products to middle income households in the United States and Canada. The company operates in three segments: Term Life Insurance; Investment and Savings Products; and Corporate and Other Distributed Products. The stock currently has a dividend yield of 1.24%. The company has a P/E ratio of 15.9. Currently, there is 1 analyst who rates Primerica a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PRI - FREE

TheStreet Quant Ratings

rates Primerica as a

buy

. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, increase in net income, revenue growth, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full

Primerica Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

GAIN Capital Holdings (GCAP) - FREE Research Report

Emerson Jason, who is Chief Financial Officer at GAIN Capital Holdings, sold 2,545 shares at $9.89 on March 10, 2015. Following this transaction, the Chief Financial Officer owned 27,203 shares meaning that the stake was reduced by 8.56% with the 2,545-share transaction.

The shares most recently traded at $9.94, up $0.05, or 0.47% since the insider transaction. Historical insider transactions for GAIN Capital Holdings go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 43,952
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 100,952
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 171,552

The average volume for GAIN Capital Holdings has been 381,700 shares per day over the past 30 days. GAIN Capital Holdings has a market cap of $437.3 million and is part of the financial sector and financial services industry. Shares are up 12.08% year-to-date as of the close of trading on Tuesday.

GAIN Capital Holdings, Inc., together with its subsidiaries, provides trading services and solutions to retail and institutional customers worldwide. The stock currently has a dividend yield of 1.97%. The company has a P/E ratio of 14.3. Currently, there are 2 analysts who rate GAIN Capital Holdings a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on GCAP - FREE

TheStreet Quant Ratings

rates GAIN Capital Holdings as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, increase in net income and growth in earnings per share. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full

GAIN Capital Holdings Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

On Assignment (ASGN) - FREE Research Report

Callaghan Brian J., who is Director at On Assignment, sold 35,263 shares at $37.77 on March 10, 2015. Following this transaction, the Director owned 673,108 shares meaning that the stake was reduced by 4.98% with the 35,263-share transaction.

Sheridan Edwin A., who is Director at On Assignment, sold 15,666 shares at $37.78 on March 10, 2015. Following this transaction, the Director owned 1.7 million shares meaning that the stake was reduced by 0.9% with the 15,666-share transaction.

The shares most recently traded at $36.87, down $0.91, or 2.47% since the insider transaction. Historical insider transactions for On Assignment go as follows:

  • 4-Week # shares sold: 214,046
  • 12-Week # shares bought: 1,006
  • 12-Week # shares sold: 214,046
  • 24-Week # shares bought: 1,006
  • 24-Week # shares sold: 214,046

The average volume for On Assignment has been 377,200 shares per day over the past 30 days. On Assignment has a market cap of $1.9 billion and is part of the services sector and diversified services industry. Shares are up 11.63% year-to-date as of the close of trading on Tuesday.

On Assignment, Inc. provides short- and long-term placement of contract, contract-to-hire, and direct hire professionals in the United States, Europe, Canada, Australia, and New Zealand. The company operates in four segments: Apex, Oxford, Physician, and Life Sciences Europe. The company has a P/E ratio of 25.9. Currently, there are 10 analysts who rate On Assignment a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on ASGN - FREE

TheStreet Quant Ratings

rates On Assignment as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year, impressive record of earnings per share growth and reasonable valuation levels. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full

On Assignment Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

null